T1	PROC 44 59	ESTUDIO CLÍNICO
#1	AnnotatorNotes T1	C0008972; Clinical Research; Research Activity | C0008976; Clinical Trials; Research Activity
T2	CHEM 112 129	HIDROXICLOROQUINA
#2	AnnotatorNotes T2	C0020336; hydroxychloroquine; Organic Chemical · Pharmacologic Substance
T3	CHEM 134 146	CICLOSPORINA
#3	AnnotatorNotes T3	C0010592; cyclosporine; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T4	CHEM 147 164	HIDROXICLOROQUINA
#4	AnnotatorNotes T4	C0020336; hydroxychloroquine; Organic Chemical · Pharmacologic Substance
T5	PROC 197 208	TRATAMIENTO
#5	AnnotatorNotes T5	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T6	CHEM 332 349	HIDROXICLOROQUINA
#6	AnnotatorNotes T6	C0020336; hydroxychloroquine; Organic Chemical · Pharmacologic Substance
T7	CHEM 353 365	CICLOSPORINA
#7	AnnotatorNotes T7	C0010592; cyclosporine; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T8	CHEM 368 385	HIDROXICLOROQUINA
#8	AnnotatorNotes T8	C0020336; hydroxychloroquine; Organic Chemical · Pharmacologic Substance
T9	PROC 392 403	TRATAMIENTO
#9	AnnotatorNotes T9	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T10	DISO 410 427	NEUMONÍA COVID-19
T11	DISO 567 590	infección por SARS-CoV2
T12	DISO 215 232	NEUMONIA COVID-19
T13	DISO 592 598	fiebre
#10	AnnotatorNotes T13	C0015967; Fever; Sign or Symptom
T14	DISO 603 606	tos
#11	AnnotatorNotes T14	C0010200; Coughing; Sign or Symptom
T15	DISO 611 617	disnea
#12	AnnotatorNotes T15	C0013404; Dyspnea; Sign or Symptom | C0476273; Respiratory distress; Sign or Symptom
T16	DISO 622 629	mialgia
#13	AnnotatorNotes T16	C0231528; Myalgia; Sign or Symptom
T17	DISO 634 641	astenia
#14	AnnotatorNotes T17	C0004093; Asthenia; Sign or Symptom
T18	DISO 646 653	diarrea
#15	AnnotatorNotes T18	C0011991; Diarrhea; Sign or Symptom
T19	DISO 693 736	infiltrados pulmonares alveolo-intersticial
#16	AnnotatorNotes T19	C0748145; PULMONARY INFILTRATE INTERSTITIAL ALVEOLAR; Disease or Syndrome
T20	ANAT 724 736	intersticial
#17	AnnotatorNotes T20	C0596790; interstitial; Body Location or Region | C2328510; Interstitium; Body Part, Organ, or Organ Component
T21	PROC 771 791	Ingreso Hospitalario
#18	AnnotatorNotes T21	C0184666; Hospital admission; Health Care Activity
T22	ANAT 716 723	alveolo
#19	AnnotatorNotes T22	C1515933; Alveolus; Body Part, Organ, or Organ Component
T23	DISO 1144 1156	intolerancia
#20	AnnotatorNotes T23	C0277585; Intolerance to drug; Pathologic Function
T24	CHEM 754 761	oxígeno
#21	AnnotatorNotes T24	C0030054; oxygen; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T25	ANAT 914 938	exudado nasal y faríngeo
T26	PROC 993 1005	prescripción
#22	AnnotatorNotes T26	C0033080; Prescription procedure; Health Care Activity | C2239117; Prescription of drug (procedure); Health Care Activity
T27	PROC 1023 1035	tratamientos
#23	AnnotatorNotes T27	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T28	PROC 1075 1099	consentimiento informado
#24	AnnotatorNotes T28	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T29	DISO 1126 1130	EPID
#25	AnnotatorNotes T29	C0746106; LUNG DISEASE INTERSTITIAL DIFFUSE; Disease or Syndrome
T30	PROC 1109 1122	diagnosticado
#26	AnnotatorNotes T30	C0011900; Diagnosis; Diagnostic Procedure
T31	DISO 1134 1141	Alergia
#27	AnnotatorNotes T31	C1527304; Allergic Reaction; Pathologic Function
T32	CHEM 1183 1194	excipientes
#28	AnnotatorNotes T32	C0015237; Pharmaceutical Excipient; Biomedical or Dental Material
T33	CHEM 1160 1176	principio activo
#29	AnnotatorNotes T33	C1372955; Active ingredient; Chemical Viewed Functionally
T34	PROC 1250 1279	tratamientos en investigación
#30	AnnotatorNotes T34	C0949266; Therapies, Investigational; Therapeutic or Preventive Procedure
T35	DISO 1288 1296	COVID-19
#31	AnnotatorNotes T35	C5203670; COVID19 (disease); Disease or Syndrome
T36	PROC 1301 1344	Tratamiento habitual con corticoides orales
T37	CHEM 1326 1337	corticoides
#32	AnnotatorNotes T37	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T38	DISO 1372 1380	COVID-19
#33	AnnotatorNotes T38	C5203670; COVID19 (disease); Disease or Syndrome
T39	DISO 1349 1359	enfermedad
#34	AnnotatorNotes T39	C0012634; Disease; Disease or Syndrome
T40	CHEM 1396 1406	prednisona
#35	AnnotatorNotes T40	C0032952; prednisone; Hormone · Organic Chemical · Pharmacologic Substance
T41	PROC 1435 1446	Tratamiento
#36	AnnotatorNotes T41	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T42	CHEM 1474 1492	inhibidores de IL1
T43	PROC 1506 1517	Tratamiento
#37	AnnotatorNotes T43	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T44	CHEM 1545 1574	inmunoglobulinas intravenosas
#38	AnnotatorNotes T44	C0085297; immunoglobulins, intravenous; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T45	PROC 1578 1589	Tratamiento
#39	AnnotatorNotes T45	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T46	PROC 1623 1642	terapias biológicas
#40	AnnotatorNotes T46	C0005527; Biological Response Modifier Therapy; Therapeutic or Preventive Procedure
T47	CHEM 1656 1665	rituximab
#41	AnnotatorNotes T47	C0393022; rituximab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T48	CHEM 1674 1692	inhibidores de Il1
T49	PROC 1702 1713	Tratamiento
#42	AnnotatorNotes T49	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T50	CHEM 1741 1750	rituximab
#43	AnnotatorNotes T50	C0393022; rituximab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T51	DISO 1754 1773	Insuficiencia renal
#44	AnnotatorNotes T51	C0035078; Kidney Failure; Disease or Syndrome | C1565489; Renal Insufficiency; Disease or Syndrome
T52	DISO 1803 1806	HTA
#45	AnnotatorNotes T52	C0020538; Hypertensive disease; Disease or Syndrome
T53	PROC 1778 1789	FG estimado
T54	PROC 1851 1876	tratamiento farmacológico
#46	AnnotatorNotes T54	C0013216; Pharmacotherapy; Therapeutic or Preventive Procedure
T55	DISO 1903 1956	proceso infeccioso bacteriano, tuberculoso, o fúngico
T56	PROC 1981 1995	Valores de AST
T57	PROC 2059 2070	Neutrófilos
#47	AnnotatorNotes T57	C0200633; Neutrophil count; Laboratory Procedure
T58	ANAT 2077 2084	células
#48	AnnotatorNotes T58	C0007634; Cells; Cell | C1269647; Entire cell; Cell
T59	PROC 2091 2100	Plaquetas
#49	AnnotatorNotes T59	C0032181; Platelet Count measurement; Laboratory Procedure
T60	ANAT 2110 2117	células
#50	AnnotatorNotes T60	C0007634; Cells; Cell | C1269647; Entire cell; Cell
T61	DISO 2125 2135	Neoplasias
#51	AnnotatorNotes T61	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C1882062; Neoplastic disease; Neoplastic Process
T62	DISO 2172 2184	Comorbilidad
#52	AnnotatorNotes T62	C1275743; Co-morbid conditions; Finding
T63	PROC 255 302	ENSAYO CLÍNICO ALEATORIZADO DE GRUPOS PARALELOS
T64	PROC 308 328	COMPARAR LA EFICACIA
#53	AnnotatorNotes T64	C1707887; Efficacy Study; Research Activity
T65	DISO 451 468	NEUMONIA COVID-19
T66	PROC 740 761	Saturación de oxígeno
#54	AnnotatorNotes T66	C0523807; Oxygen saturation measurement; Laboratory Procedure
T67	ANAT 705 715	pulmonares
#55	AnnotatorNotes T67	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T68	PROC 170 190	COMPARAR SU EFICACIA
T69	PROC 895 910	PCR de SAR-CoV2
#56	AnnotatorNotes T69	C5244035; SARS-CoV-2 PCR test; Laboratory Procedure | C5541700; PCR for SARS-CoV-2; Laboratory Procedure
T70	PROC 88 101	ALEATORIZADOS
#57	AnnotatorNotes T70	C0034656; Randomization; Research Activity
T71	ANAT 1768 1773	renal
#58	AnnotatorNotes T71	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T72	PROC 1827 1829	TA
T73	CHEM 1992 1995	AST
#59	AnnotatorNotes T73	C0004002; Aspartate Transaminase; Amino Acid, Peptide, or Protein · Enzyme
T74	PROC 1996 1999	ALT
#60	AnnotatorNotes T74	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T75	Date 12 16	2020
T76	LIVB 74 83	PACIENTES
#61	AnnotatorNotes T76	C0030705; Patients; Patient or Disabled Group
T77	LIVB 497 503	Adulto
#62	AnnotatorNotes T77	C0001675; Adult; Age Group
T78	Age 504 525	≥ 18 años y < 80 años
T79	Duration 655 663	≤ 7 días
T81	LIVB 806 814	paciente
#63	AnnotatorNotes T81	C0030705; Patients; Patient or Disabled Group
T82	Neg_cue 1052 1066	Incapacidad de
T83	LIVB 1206 1214	paciente
#64	AnnotatorNotes T83	C0030705; Patients; Patient or Disabled Group
T84	Route 1338 1344	orales
#65	AnnotatorNotes T84	C1527415; Oral Route of Drug administration; Functional Concept
T85	Dose 1383 1392	una dosis
T86	Dose 1407 1413	>10 mg
T87	Frequency 1413 1417	/día
T88	Duration 1450 1469	los 30 días previos
T89	Duration 1521 1540	los 2 meses previos
T90	Route 1562 1574	intravenosas
#66	AnnotatorNotes T90	C1522726; Intravenous Route of Drug Administration; Functional Concept
T91	Duration 1593 1612	los 2 meses previos
T92	Duration 1717 1736	los 6 meses previos
T95	LIVB 1922 1932	bacteriano
#67	AnnotatorNotes T95	C0004611; Bacteria; Bacterium
T96	LIVB 1949 1956	fúngico
#68	AnnotatorNotes T96	C0016832; Fungi; Fungus
T97	PHYS 2147 2155	Embarazo
#69	AnnotatorNotes T97	C0032961; Pregnancy; Organism Function
T98	PHYS 2158 2167	lactancia
#70	AnnotatorNotes T98	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T101	LIVB 581 590	SARS-CoV2
#71	AnnotatorNotes T101	C5203676; SARS-CoV-2; Virus
T80	LIVB 902 910	SAR-CoV2
#72	AnnotatorNotes T80	C5203676; SARS-CoV-2; Virus
T93	Neg_cue 1360 1371	diferente a
T94	Neg_cue 1643 1655	diferentes a
T99	PHYS 1778 1780	FG
#73	AnnotatorNotes T99	C0232809; Glomerular filtration; Organ or Tissue Function
A1	Assertion T28 Negated
A2	Assertion T38 Negated
A3	Assertion T47 Negated
A4	Assertion T48 Negated
A6	Assertion T27 Contraindicated
A5	Status T23 History_of
A7	Status T31 History_of
#74	AnnotatorNotes T68	C1707887; Efficacy Study; Research Activity
#75	AnnotatorNotes T12	C5419163; COVID-19-Associated Pneumonia; Disease or Syndrome 
#76	AnnotatorNotes T10	C5419163; COVID-19-Associated Pneumonia; Disease or Syndrome 
#77	AnnotatorNotes T65	C5419163; COVID-19-Associated Pneumonia; Disease or Syndrome 
#78	AnnotatorNotes T63	C0206034; Clinical Trials, Randomized; Research Activity + C2826345; Parallel Study; Research Activity 
#79	AnnotatorNotes T11	C5203670; COVID19 (disease); Disease or Syndrome
#80	AnnotatorNotes T53	C0C3811844; Estimated Glomerular Filtration Rate; Laboratory Procedure
#81	AnnotatorNotes T56	C0201899; Aspartate aminotransferase measurement; Laboratory Procedure
R1	Negation Arg1:T93 Arg2:T38	
R2	Negation Arg1:T94 Arg2:T47	
R3	Negation Arg1:T94 Arg2:T48	
R4	Experiences Arg1:T76 Arg2:T2	
R5	Before Arg1:T70 Arg2:T2	
R6	Before Arg1:T70 Arg2:T3	
R7	Experiences Arg1:T76 Arg2:T3	
R8	Combined_with Arg1:T3 Arg2:T4	
R9	Combined_with Arg1:T7 Arg2:T8	
R10	Used_for Arg1:T6 Arg2:T9	
R11	Used_for Arg1:T7 Arg2:T9	
R12	Used_for Arg1:T3 Arg2:T5	
R13	Used_for Arg1:T2 Arg2:T5	
R14	Experiences Arg1:T76 Arg2:T5	
R15	Experiences Arg1:T76 Arg2:T12	
R16	Has_Age Arg1:T77 Arg2:T78	
T100	DISO 529 536	Clínica
#82	AnnotatorNotes T100	C0037088; Signs and Symptoms; Sign or Symptom
R17	Causes Arg1:T101 Arg2:T11	
R18	Causes Arg1:T11 Arg2:T100	
R19	Causes Arg1:T11 Arg2:T13	
R20	Causes Arg1:T11 Arg2:T14	
R21	Causes Arg1:T11 Arg2:T15	
R22	Causes Arg1:T11 Arg2:T16	
R23	Causes Arg1:T11 Arg2:T17	
R24	Causes Arg1:T11 Arg2:T18	
R25	Has_Duration_or_Interval Arg1:T100 Arg2:T79	
R26	Has_Duration_or_Interval Arg1:T13 Arg2:T79	
R27	Has_Duration_or_Interval Arg1:T14 Arg2:T79	
R28	Has_Duration_or_Interval Arg1:T15 Arg2:T79	
R29	Has_Duration_or_Interval Arg1:T16 Arg2:T79	
R30	Has_Duration_or_Interval Arg1:T17 Arg2:T79	
R31	Has_Duration_or_Interval Arg1:T18 Arg2:T79	
T102	Quantifier_or_Qualifier 537 544	inicial
#83	AnnotatorNotes T102	C0205265; Initially; Temporal Concept
R32	Has_Quantifier_or_Qualifier Arg1:T100 Arg2:T102	
R33	Location_of Arg1:T67 Arg2:T19	
R34	Location_of Arg1:T22 Arg2:T19	
R35	Location_of Arg1:T20 Arg2:T19	
T103	Quantifier_or_Qualifier 762 767	basal
#84	AnnotatorNotes T103	C1442488; Baseline; Quantitative Concept
R36	Has_Quantifier_or_Qualifier Arg1:T66 Arg2:T103	
T104	CONC 828 871	escala ordinal de mejoría clínica de la OMS
T105	Result_or_Value 815 818	≥ 3
R37	Has_Result_or_Value Arg1:T104 Arg2:T105	
R38	Location_of Arg1:T25 Arg2:T69	
R39	Before Arg1:T26 Arg2:T27	
A8	Assertion T26 Contraindicated
R40	Negation Arg1:T82 Arg2:T28	
R41	Causes Arg1:T33 Arg2:T31	
R42	Causes Arg1:T33 Arg2:T23	
R43	Causes Arg1:T32 Arg2:T31	
R44	Causes Arg1:T32 Arg2:T23	
R45	Experiences Arg1:T83 Arg2:T34	
R46	Experiences Arg1:T83 Arg2:T35	
T106	Observation 1218 1239	participe en estudios
#85	AnnotatorNotes T106	C1278516; Patient participation status; Finding
R47	Overlap Arg1:T106 Arg2:T34	
R48	Used_for Arg1:T37 Arg2:T36	
R49	Has_Route_or_Mode Arg1:T37 Arg2:T84	
R50	Has_Dose_or_Strength Arg1:T40 Arg2:T85	
R51	Used_for Arg1:T40 Arg2:T36	
R52	Has_Route_or_Mode Arg1:T40 Arg2:T84	
R53	Has_Dose_or_Strength Arg1:T40 Arg2:T86	
R54	Has_Frequency Arg1:T40 Arg2:T87	
T107	CONC 1396 1406;1420 1431	prednisona equivalente
R55	Used_for Arg1:T42 Arg2:T41	
T108	CHEM 1474 1485;1495 1501	inhibidores de IL6
#86	AnnotatorNotes T108	C5690764; Interleukin-6 Inhibitors; Organic Chemical · Pharmacologic Substance
R56	Used_for Arg1:T108 Arg2:T41	
R57	Overlap Arg1:T108 Arg2:T88	
R58	Overlap Arg1:T42 Arg2:T88	
R59	Used_for Arg1:T44 Arg2:T43	
R60	Overlap Arg1:T44 Arg2:T89	
R61	Has_Route_or_Mode Arg1:T44 Arg2:T90	
R62	Overlap Arg1:T45 Arg2:T91	
R63	Overlap Arg1:T46 Arg2:T91	
T109	CHEM 1674 1688;1695 1698	inhibidores de Il6
#87	AnnotatorNotes T109	C5690764; Interleukin-6 Inhibitors; Organic Chemical · Pharmacologic Substance
R64	Negation Arg1:T94 Arg2:T109	
A9	Assertion T109 Negated
R65	Overlap Arg1:T50 Arg2:T92	
R66	Used_for Arg1:T50 Arg2:T49	
R67	Location_of Arg1:T71 Arg2:T51	
R70	Location_of Arg1:T71 Arg2:T99	
T110	Result_or_Value 1790 1800	< 30ml/min
R71	Has_Result_or_Value Arg1:T53 Arg2:T110	
T111	Observation 1810 1825	difícil control
#88	AnnotatorNotes T111	C0742800; CONTROL DIFFICULT; Finding
R72	Has_Quantifier_or_Qualifier Arg1:T52 Arg2:T111	
T112	Result_or_Value 1830 1839	> 180/100
#89	AnnotatorNotes T72	C0005824; Blood pressure determination; Health Care Activity
R73	Has_Result_or_Value Arg1:T72 Arg2:T112	
T113	Quantifier_or_Qualifier 1877 1885	adecuado
#90	AnnotatorNotes T113	C0205411; Adequate; Qualitative Concept
R78	Has_Quantifier_or_Qualifier Arg1:T54 Arg2:T113	
R79	Causes Arg1:T95 Arg2:T55	
R80	Causes Arg1:T96 Arg2:T55	
T114	Quantifier_or_Qualifier 1957 1963	activo
#91	AnnotatorNotes T114	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R81	Has_Quantifier_or_Qualifier Arg1:T55 Arg2:T114	
T115	Quantifier_or_Qualifier 1964 1977	intercurrente
R82	Has_Quantifier_or_Qualifier Arg1:T55 Arg2:T115	
#92	AnnotatorNotes T55	C0004623; Bacterial Infections; Disease or Syndrome | C0041296; Tuberculosis; Disease or Syndrome | C0026946; Mycoses; Disease or Syndrome
T116	Result_or_Value 2000 2056	superiores a 5 veces el límite superior de la normalidad
R83	Has_Result_or_Value Arg1:T56 Arg2:T116	
R84	Has_Result_or_Value Arg1:T74 Arg2:T116	
T117	Result_or_Value 2071 2088	< 500 células/mm3
R85	Has_Result_or_Value Arg1:T57 Arg2:T117	
T118	Result_or_Value 2101 2121	< 50.000 células/mm3
R86	Has_Result_or_Value Arg1:T59 Arg2:T118	
T119	Quantifier_or_Qualifier 2136 2143	activas
#93	AnnotatorNotes T119	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R87	Has_Quantifier_or_Qualifier Arg1:T61 Arg2:T119	
T120	Quantifier_or_Qualifier 2185 2195	importante
#94	AnnotatorNotes T120	C3898777; Important; Qualitative Concept
R88	Has_Quantifier_or_Qualifier Arg1:T62 Arg2:T120	
T121	CONC 2197 2208	Escala CIRS
#95	AnnotatorNotes T121	C4525403; Cumulative Illness Rating Scale for Geriatrics; Intellectual Product
T122	Result_or_Value 2209 2212	>29
R89	Has_Result_or_Value Arg1:T121 Arg2:T122	
#96	AnnotatorNotes T42	C1504688; IL1RN protein, human; Amino Acid, Peptide, or Protein · Biologically Active Substance (?)
#97	AnnotatorNotes T48	C1504688; IL1RN protein, human; Amino Acid, Peptide, or Protein · Biologically Active Substance (?)
A10	Experiencer T76 Patient
A11	Experiencer T77 Patient
A12	Experiencer T81 Patient
A13	Experiencer T83 Patient
T123	Result_or_Value 875 886	Positividad
R68	Has_Result_or_Value Arg1:T69 Arg2:T123	
